Chinese Journal of Pharmacovigilance ›› 2018, Vol. 15 ›› Issue (11): 699-700.
• Orginal Article • Previous Articles Next Articles
YU Jin, WU Jingjing, BIAN Hailin*
Received:2018-05-09
Revised:2019-01-09
Online:2018-11-20
Published:2019-01-09
CLC Number:
YU Jin, WU Jingjing, BIAN Hailin. One Case of Rapid Increase of γ-glutamyltransferase Induced by Biapenem for Injection[J]. Chinese Journal of Pharmacovigilance, 2018, 15(11): 699-700.
| [1] 赵颖,邹文卫. 比阿培南治疗中重度卒中相关性肺炎疗效观察[J]. 中国实用神经疾病杂志, 2011,14(17):35-38. [2] 赵媛媛,王屏,银洪汝. 碳青霉烯类抗菌药物致不良反应文献分析[J]. 中国药房,2013,24(10):933-935. [3] 国家食品药品监督管理局药品安全监管司, 国家药品不良反应中心. 药品不良反应报告和监测工作手册[S]. 2005:46. [4] 杜文民,王永民,程能能. 药品不良反应的判定与其研究方法[J]. 中国药物警戒,2005,2(1):11-13,28. [5] 魏戌,谢雁. 国内外不良反应因果判断原则及评价方法解读[J]. 中国中药杂志,2012,37(18):2744-2747. [6] 位松华. ALT、AST、ALP、γ-GT组合实验室检验结果分析在各类肝胆疾病诊断中的临床价值[J]. 检验医学与临床,2016,13(6):848-849. [7] Zhang Y, Yu C L, Zhao M, et al.Effects of fluoroquinolones on the cytochrome P450 enzyme system of rat liver microsomes[J]. Med J Chin PLA, 2012,37(11):1059-1063. [8] Ho N, Youjyu K, Hiroyuki Y, et al.The efficacy, safety, and pharmacokinetics of biapenem administered thrice daily for the treatment of pneumonia in the elderly[J]. Journal of infection and chemotherapy: official journal of the Japan Society of Chemotherapy, 2014,20(6):356-360. [9] 李楠,徐正婕. 抗菌药物对肝脏的影响及在肝病治疗中的应用[J]. 世界临床药物,2011,32(9):521-525. [10] 朱磊,黄萍,李颖. 162例药物性肝损害不良反应/事件报告分析[J]. 中国药物警戒,2013,10(7):415-418. [11] 关晓媛,任进强. 浅谈抗菌药物的不良反应及应对措施[J]. 中国保健营养,2012,6(10):1710. |
| [1] | SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131. |
| [2] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136. |
| [3] | BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140. |
| [4] | JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166. |
| [5] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
| [6] | FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184. |
| [7] | ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189. |
| [8] | WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194. |
| [9] | LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198. |
| [10] | XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203. |
| [11] | GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207. |
| [12] | FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210. |
| [13] | LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212. |
| [14] | CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218. |
| [15] | ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
